U.S. Cannabis Market Growth, Size, Trends Analysis - By Source, By Derivative, By Cultivation, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
Description
U.S. Cannabis Market Introduction and Overview
According to SPER market research, ‘U.S. Cannabis Market Size- By Source, By Derivative, By Cultivation, By End-User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the U.S. Cannabis Market is predicted to reach 119.79 billion by 2034 with a CAGR of 11.77%.
Cannabis, widely referred to as marijuana, weed, or pot, is a psychoactive substance derived from the cannabis plant. It possesses a long-standing history of utilization, serving both medical and recreational purposes. For centuries, it has been part of various cultural, religious, and spiritual practices. The drug can be consumed in multiple forms, including smoking dried flowers, using extracts like hashish, or incorporating it into food and beverages.
Restraints: The cannabis market also encounters considerable limitations due to stringent regulatory frameworks and varying legal statuses across different regions. Although some nations and states have sanctioned medical or recreational cannabis, numerous others continue to enforce strict prohibitions. Additionally, even in areas where cannabis is legalized, challenges such as taxation policies, intricate licensing requirements, and compliance costs confront market players.
Scope of the report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered
By Source, By Derivative, By Cultivation, By End-User
Regions covered
Northeast, Midwest, West, South
Companies Covered
Medical Marijuana, Inc, NuLeaf Naturals, LLC, CV Sciences, Inc, CHARLOTTE'S WEB, The Cronos Group, Organigram Holding, Inc, Irwin Naturals, Tilray Brands, Canopy Growth Corporation, Aurora Cannabis.
U.S. Cannabis Market Segmentation:
By Source: Based on the Source, U.S. Cannabis Market is segmented as; Hemp, Marijuana.
By Derivatives: Based on the Derivatives, U.S. Cannabis Market is segmented as; CBD, THC.
By Cultivation: Based on the Cultivation, U.S. Cannabis Market is segmented as; Indoor Cultivation, Greenhouse Cultivation, Outdoor Cultivation.
By End User: Based on the End User, U.S. Cannabis Market is segmented as; Industrial Use, Medical Use, Recreational Use.
By Region: This research also includes data for Northeast, Midwest, West, South.
According to SPER market research, ‘U.S. Cannabis Market Size- By Source, By Derivative, By Cultivation, By End-User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the U.S. Cannabis Market is predicted to reach 119.79 billion by 2034 with a CAGR of 11.77%.
Cannabis, widely referred to as marijuana, weed, or pot, is a psychoactive substance derived from the cannabis plant. It possesses a long-standing history of utilization, serving both medical and recreational purposes. For centuries, it has been part of various cultural, religious, and spiritual practices. The drug can be consumed in multiple forms, including smoking dried flowers, using extracts like hashish, or incorporating it into food and beverages.
Restraints: The cannabis market also encounters considerable limitations due to stringent regulatory frameworks and varying legal statuses across different regions. Although some nations and states have sanctioned medical or recreational cannabis, numerous others continue to enforce strict prohibitions. Additionally, even in areas where cannabis is legalized, challenges such as taxation policies, intricate licensing requirements, and compliance costs confront market players.
Scope of the report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered
By Source, By Derivative, By Cultivation, By End-User
Regions covered
Northeast, Midwest, West, South
Companies Covered
Medical Marijuana, Inc, NuLeaf Naturals, LLC, CV Sciences, Inc, CHARLOTTE'S WEB, The Cronos Group, Organigram Holding, Inc, Irwin Naturals, Tilray Brands, Canopy Growth Corporation, Aurora Cannabis.
U.S. Cannabis Market Segmentation:
By Source: Based on the Source, U.S. Cannabis Market is segmented as; Hemp, Marijuana.
By Derivatives: Based on the Derivatives, U.S. Cannabis Market is segmented as; CBD, THC.
By Cultivation: Based on the Cultivation, U.S. Cannabis Market is segmented as; Indoor Cultivation, Greenhouse Cultivation, Outdoor Cultivation.
By End User: Based on the End User, U.S. Cannabis Market is segmented as; Industrial Use, Medical Use, Recreational Use.
By Region: This research also includes data for Northeast, Midwest, West, South.
Table of Contents
148 Pages
- 1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
- 6. Competitive Landscape
- 6.1. U. S. Cannabis Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in U. S. Cannabis Market
- 7. U. S. Cannabis Market, By Source (USD Million) 2021-2034
- 7.1. Hemp
- 7.1.1. Hemp Oil
- 7.1.2. Industrial Hemp
- 7.2. Marijuana
- 7.2.1. Flower
- 7.2.2. Oil and Tinctures
- 8. U. S. Cannabis Market, By Derivatives (USD Million) 2021-2034
- 8.1. CBD
- 8.2. THC
- 8.3. Others
- 9. U. S. Cannabis Market, By Cultivation (USD Million) 2021-2034
- 9.1. Indoor Cultivation
- 9.2. Greenhouse Cultivation
- 9.3. Outdoor Cultivation
- 10. U. S. Cannabis Market, By End User (USD Million) 2021-2034
- 10.1. Industrial Use
- 10.2. Medical Use
- 10.2.1. Chronic Pain
- 10.2.2. Depression and Anxiety
- 10.2.3. Arthritis
- 10.2.4. Post-Traumatic Stress Disorder (PTSD)
- 10.2.5. Cancer
- 10.2.6. Migraines
- 10.2.7. Epilepsy
- 10.2.8. Alzheimer’s Disease
- 10.2.9. Multiple Sclerosis
- 10.2.10. AIDS
- 10.2.11. Amyotrophic Lateral Sclerosis
- 10.2.12. Tourette’s Syndrome
- 10.2.13. Diabetes
- 10.2.14. Parkinson's Disease
- 10.2.15. Glaucoma
- 10.2.16. Others
- 10.3. Recreational Use
- 11. U. S. Cannabis Market, (USD Million) 2021-2034
- 11.1. U. S. Cannabis Market Size and Market Share
- 12. U. S. Cannabis Market, By Region, (USD Million) 2021-2034
- 12.1. Northeast
- 12.2. Midwest
- 12.3. West
- 12.4. South
- 13. Company Profile
- 13.1. Medical Marijuana, Inc
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
- 13.2. NuLeaf Naturals, LLC
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
- 13.3. CV Sciences, Inc
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
- 13.4. CHARLOTTE’S WEB
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
- 13.5. The Cronos Group
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
- 13.6. Organigram Holding, Inc
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
- 13.7. Irwin Naturals
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
- 13.8. Tilray Brands
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
- 13.9. Canopy Growth Corporation
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
- 13.10. Aurora Cannabis
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3. Product summary
- 13.10.4. Recent developments
- 13.11. Others
- 14. Conclusion
- 15. List of Abbreviations
- 16. Reference Links
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
